About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:4420974
Allelic
Composition
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
Genetic
Background
involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptentm1Hwu mutation (16 available); any Pten mutation (88 available)
Tg(Pbsn-cre)4Prb mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 3 of 14 mice die by age 12 to 29 weeks
• however, all castrated mice survive from 7 to 10 months
• 12 month survival rate of mutants is 60% on the high-omega-3 diet, 10% on the low-omega-3 diet and 0% on the high-omega-6 diet
• mutants on a high-omega-6 diet do not survive beyond 10 months of age and die due to bladder obstruction by the prostate tumor compressing the urethra

reproductive system
• prostate lobes are enlarged and exhibit increased vascularity and cellularity
• at 4 weeks, epithelium cells in the lateral prostate are larger than in Ptentm1Hwu homozygotes
• without cellular atypia by 4 weeks of age
• mice exhibit progressive enlargement of the prostate gland compared to in Ptentm1Hwu homozygotes
• however, castration reduces prostate size
• prostate weight is higher than in controls starting at 8 weeks of age
• prostate weight gain from 5 to 24 weeks is significantly less in mice fed a high-omega-3 diet than in mice fed a high-omega-6 diet
• at 4 weeks, mice develop multifocal hyperplasia compared to in Ptentm1Hwu homozygotes
• hyperplasia is initially observed in the dorsolateral and ventral lobe with subsequent involvement of the anterior lobes
• males develop prostate cancer
• mice develop invasive adenocarcinoma by 9 weeks of age in all lobes (J:93902)
• prostate cancers are metastatic (J:93902)
• castrated mice still develop invasive adenocarcinoma (J:93902)
• 80% of mutants fed a high-omega-6 diet develop invasive carcinoma while 50% of mutants fed a high-omega-3 diet develop invasive carcinoma (J:124208)
• by 6 weeks of age, all mice develop prostate intraepithelial neoplasia (J:93902)
• latency to prostate intraepithelial neoplasia is 1.5 months (J:93902)
• males develop PIN lesions after 16 months of age (J:106650)
• prostate cancer cells exhibit increased proliferation compared to in Ptentm1Hwu homozygotes (J:93902)
• cancer cells induce a desmoplastic response (J:93902)
• castrated mice exhibit increased proliferation compared with similarly treated Ptentm1Hwu homozygotes (J:93902)
• higher numbers of apoptotic cells are seen in mutant prostates from mice on the high-omega-3 diet than on the high-omega-6 diet (J:124208)
• cancer cells induce inflammation

neoplasm
• males develop prostate cancer
• mice develop invasive adenocarcinoma by 9 weeks of age in all lobes (J:93902)
• prostate cancers are metastatic (J:93902)
• castrated mice still develop invasive adenocarcinoma (J:93902)
• 80% of mutants fed a high-omega-6 diet develop invasive carcinoma while 50% of mutants fed a high-omega-3 diet develop invasive carcinoma (J:124208)
• by 6 weeks of age, all mice develop prostate intraepithelial neoplasia (J:93902)
• latency to prostate intraepithelial neoplasia is 1.5 months (J:93902)
• males develop PIN lesions after 16 months of age (J:106650)
• omega-3 polyunsaturated fatty acids (PUFAs) slow the progression of prostate tumors in 5- to 8-week old mutants; once carcinoma develops, omega-3 PUFAs induce apoptosis and decrease the growth of the tumor

immune system
• cancer cells induce inflammation
• mutants surviving 6 months or longer exhibit pyelonephritis

endocrine/exocrine glands
• prostate lobes are enlarged and exhibit increased vascularity and cellularity
• at 4 weeks, epithelium cells in the lateral prostate are larger than in Ptentm1Hwu homozygotes
• without cellular atypia by 4 weeks of age
• mice exhibit progressive enlargement of the prostate gland compared to in Ptentm1Hwu homozygotes
• however, castration reduces prostate size
• prostate weight is higher than in controls starting at 8 weeks of age
• prostate weight gain from 5 to 24 weeks is significantly less in mice fed a high-omega-3 diet than in mice fed a high-omega-6 diet
• at 4 weeks, mice develop multifocal hyperplasia compared to in Ptentm1Hwu homozygotes
• hyperplasia is initially observed in the dorsolateral and ventral lobe with subsequent involvement of the anterior lobes
• males develop prostate cancer
• mice develop invasive adenocarcinoma by 9 weeks of age in all lobes (J:93902)
• prostate cancers are metastatic (J:93902)
• castrated mice still develop invasive adenocarcinoma (J:93902)
• 80% of mutants fed a high-omega-6 diet develop invasive carcinoma while 50% of mutants fed a high-omega-3 diet develop invasive carcinoma (J:124208)
• by 6 weeks of age, all mice develop prostate intraepithelial neoplasia (J:93902)
• latency to prostate intraepithelial neoplasia is 1.5 months (J:93902)
• males develop PIN lesions after 16 months of age (J:106650)
• prostate cancer cells exhibit increased proliferation compared to in Ptentm1Hwu homozygotes (J:93902)
• cancer cells induce a desmoplastic response (J:93902)
• castrated mice exhibit increased proliferation compared with similarly treated Ptentm1Hwu homozygotes (J:93902)
• higher numbers of apoptotic cells are seen in mutant prostates from mice on the high-omega-3 diet than on the high-omega-6 diet (J:124208)
• cancer cells induce inflammation

renal/urinary system
• mutants surviving 6 months or longer exhibit retention of urine in the anterior prostate lobes
• mutants surviving 6 months or longer exhibit pyelonephritis


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory